Back
Royal Gold Vs. Dyne Therapeutics Industry Stock Comparison
Buy
52
RGLD
Royal Gold
Last Price:
125.17
Seasonality Move:
8.3%
Buy
70
DYN
Dyne Therapeutics
Last Price:
35.34
Seasonality Move:
14.48%
Buy
52
Royal Gold (RGLD)
is a Buy
Is Royal Gold a Buy, Sell or Hold?
- The current Royal Gold [RGLD] share price is $125.16. The Score for RGLD is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- RGLD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
70
Dyne Therapeutics (DYN)
is a Buy
Is Dyne Therapeutics a Buy, Sell or Hold?
- The current Dyne Therapeutics [DYN] share price is $35.34. The Score for DYN is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- DYN is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RGLD Stock Price Chart
What is Royal Gold's stock price today?
-
The Royal Gold share price today is $125.16
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RGLD is experiencing slight selling pressure.
DYN Stock Price Chart
What is Dyne Therapeutics's stock price today?
-
The Dyne Therapeutics share price today is $35.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DYN is experiencing slight buying pressure.
RGLD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 50.69 | Buy |
| Chaikin Money Flow: | -130957 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.58 - 128.44) | Sell |
| Bollinger Bands (100): | (111.17 - 127.47) | Buy |
DYN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.4 | Buy |
| Relative Strength Index (14 RSI): | 61.32 | Buy |
| Chaikin Money Flow: | 956037 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (31.02 - 34.14) | Buy |
| Bollinger Bands (100): | (24.19 - 31.31) | Buy |
RGLD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 124.39 | Buy |
| 20-day SMA: | 124.69 | Buy |
| 50-day SMA: | 125.43 | Sell |
| 200-day SMA: | 116.57 | Buy |
| 8-day EMA: | 124.53 | Buy |
| 20-day EMA: | 124.81 | Buy |
| 50-day EMA: | 124.19 | Buy |
| 200-day EMA: | 119.23 | Buy |
DYN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.34 | Buy |
| 20-day SMA: | 32.99 | Buy |
| 50-day SMA: | 29.68 | Buy |
| 200-day SMA: | 19.72 | Buy |
| 8-day EMA: | 34.37 | Buy |
| 20-day EMA: | 33.08 | Buy |
| 50-day EMA: | 30.6 | Buy |
| 200-day EMA: | 22.62 | Buy |
Royal Gold Earnings Growth & RGLD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.36 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.12 per share, and an increase next year of $1.26 per share.
Dyne Therapeutics Earnings Growth & DYN Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.05 per share, an increase this year of $0.77 per share, and an increase next year of $0.16 per share.
Royal Gold Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Dyne Therapeutics Technical Analysis
| Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||